Due to the COVID-19 pandemic, the global Flutamide (CAS 13311-84-7) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Flutamide Tablets accounting for % of the Flutamide (CAS 13311-84-7) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.

Flutamide is used for prostate cancer or benign prostatic hypertrophy. This product can be combined with leucolide to treat metastatic prostate cancer, which can significantly increase the efficacy.

Global Flutamide (CAS 13311-84-7) Scope and Segment

Flutamide (CAS 13311-84-7) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Flutamide (CAS 13311-84-7) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Flutamide Tablets

Flutamide Capsule

Others

Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

BY COMPANY

Forward

Merck

Tasly Diyi Pharma

Cipla LifeScience

Actiza Pharma

TEVA Pharma

Florencia Healthcare

SANDOZ

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

1 Study Coverage

1.1 Flutamide (CAS 13311-84-7) Product Introduction

1.2 Market by Type

1.2.1 Global Flutamide (CAS 13311-84-7) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Flutamide Tablets

1.2.3 Flutamide Capsule

1.2.4 Others

1.3 Market by Application

1.3.1 Global Flutamide (CAS 13311-84-7) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Flutamide (CAS 13311-84-7) Sales Estimates and Forecasts 2017-2028

2.2 Global Flutamide (CAS 13311-84-7) Revenue Estimates and Forecasts 2017-2028

2.3 Global Flutamide (CAS 13311-84-7) Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Flutamide (CAS 13311-84-7) Sales by Region

2.4.1 Global Flutamide (CAS 13311-84-7) Sales by Region (2017-2022)

2.4.2 Global Sales Flutamide (CAS 13311-84-7) by Region (2023-2028)

2.5 Global Flutamide (CAS 13311-84-7) Revenue by Region

2.5.1 Global Flutamide (CAS 13311-84-7) Revenue by Region (2017-2022)

2.5.2 Global Flutamide (CAS 13311-84-7) Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Flutamide (CAS 13311-84-7) Sales by Manufacturers

3.1.1 Global Top Flutamide (CAS 13311-84-7) Manufacturers by Sales (2017-2022)

3.1.2 Global Flutamide (CAS 13311-84-7) Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Flutamide (CAS 13311-84-7) in 2021

3.2 Global Flutamide (CAS 13311-84-7) Revenue by Manufacturers

3.2.1 Global Flutamide (CAS 13311-84-7) Revenue by Manufacturers (2017-2022)

3.2.2 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Flutamide (CAS 13311-84-7) Revenue in 2021

3.3 Global Flutamide (CAS 13311-84-7) Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Flutamide (CAS 13311-84-7) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Flutamide (CAS 13311-84-7) Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Flutamide (CAS 13311-84-7) Sales by Type

4.1.1 Global Flutamide (CAS 13311-84-7) Historical Sales by Type (2017-2022)

4.1.2 Global Flutamide (CAS 13311-84-7) Forecasted Sales by Type (2023-2028)

4.1.3 Global Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2028)

4.2 Global Flutamide (CAS 13311-84-7) Revenue by Type

4.2.1 Global Flutamide (CAS 13311-84-7) Historical Revenue by Type (2017-2022)

4.2.2 Global Flutamide (CAS 13311-84-7) Forecasted Revenue by Type (2023-2028)

4.2.3 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2028)

4.3 Global Flutamide (CAS 13311-84-7) Price by Type

4.3.1 Global Flutamide (CAS 13311-84-7) Price by Type (2017-2022)

4.3.2 Global Flutamide (CAS 13311-84-7) Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Flutamide (CAS 13311-84-7) Sales by Application

5.1.1 Global Flutamide (CAS 13311-84-7) Historical Sales by Application (2017-2022)

5.1.2 Global Flutamide (CAS 13311-84-7) Forecasted Sales by Application (2023-2028)

5.1.3 Global Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2028)

5.2 Global Flutamide (CAS 13311-84-7) Revenue by Application

5.2.1 Global Flutamide (CAS 13311-84-7) Historical Revenue by Application (2017-2022)

5.2.2 Global Flutamide (CAS 13311-84-7) Forecasted Revenue by Application (2023-2028)

5.2.3 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2017-2028)

5.3 Global Flutamide (CAS 13311-84-7) Price by Application

5.3.1 Global Flutamide (CAS 13311-84-7) Price by Application (2017-2022)

5.3.2 Global Flutamide (CAS 13311-84-7) Price Forecast by Application (2023-2028)

6 North America

6.1 North America Flutamide (CAS 13311-84-7) Market Size by Type

6.1.1 North America Flutamide (CAS 13311-84-7) Sales by Type (2017-2028)

6.1.2 North America Flutamide (CAS 13311-84-7) Revenue by Type (2017-2028)

6.2 North America Flutamide (CAS 13311-84-7) Market Size by Application

6.2.1 North America Flutamide (CAS 13311-84-7) Sales by Application (2017-2028)

6.2.2 North America Flutamide (CAS 13311-84-7) Revenue by Application (2017-2028)

6.3 North America Flutamide (CAS 13311-84-7) Market Size by Country

6.3.1 North America Flutamide (CAS 13311-84-7) Sales by Country (2017-2028)

6.3.2 North America Flutamide (CAS 13311-84-7) Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Flutamide (CAS 13311-84-7) Market Size by Type

7.1.1 Europe Flutamide (CAS 13311-84-7) Sales by Type (2017-2028)

7.1.2 Europe Flutamide (CAS 13311-84-7) Revenue by Type (2017-2028)

7.2 Europe Flutamide (CAS 13311-84-7) Market Size by Application

7.2.1 Europe Flutamide (CAS 13311-84-7) Sales by Application (2017-2028)

7.2.2 Europe Flutamide (CAS 13311-84-7) Revenue by Application (2017-2028)

7.3 Europe Flutamide (CAS 13311-84-7) Market Size by Country

7.3.1 Europe Flutamide (CAS 13311-84-7) Sales by Country (2017-2028)

7.3.2 Europe Flutamide (CAS 13311-84-7) Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Flutamide (CAS 13311-84-7) Market Size by Type

8.1.1 Asia Pacific Flutamide (CAS 13311-84-7) Sales by Type (2017-2028)

8.1.2 Asia Pacific Flutamide (CAS 13311-84-7) Revenue by Type (2017-2028)

8.2 Asia Pacific Flutamide (CAS 13311-84-7) Market Size by Application

8.2.1 Asia Pacific Flutamide (CAS 13311-84-7) Sales by Application (2017-2028)

8.2.2 Asia Pacific Flutamide (CAS 13311-84-7) Revenue by Application (2017-2028)

8.3 Asia Pacific Flutamide (CAS 13311-84-7) Market Size by Region

8.3.1 Asia Pacific Flutamide (CAS 13311-84-7) Sales by Region (2017-2028)

8.3.2 Asia Pacific Flutamide (CAS 13311-84-7) Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Flutamide (CAS 13311-84-7) Market Size by Type

9.1.1 Latin America Flutamide (CAS 13311-84-7) Sales by Type (2017-2028)

9.1.2 Latin America Flutamide (CAS 13311-84-7) Revenue by Type (2017-2028)

9.2 Latin America Flutamide (CAS 13311-84-7) Market Size by Application

9.2.1 Latin America Flutamide (CAS 13311-84-7) Sales by Application (2017-2028)

9.2.2 Latin America Flutamide (CAS 13311-84-7) Revenue by Application (2017-2028)

9.3 Latin America Flutamide (CAS 13311-84-7) Market Size by Country

9.3.1 Latin America Flutamide (CAS 13311-84-7) Sales by Country (2017-2028)

9.3.2 Latin America Flutamide (CAS 13311-84-7) Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Flutamide (CAS 13311-84-7) Market Size by Type

10.1.1 Middle East and Africa Flutamide (CAS 13311-84-7) Sales by Type (2017-2028)

10.1.2 Middle East and Africa Flutamide (CAS 13311-84-7) Revenue by Type (2017-2028)

10.2 Middle East and Africa Flutamide (CAS 13311-84-7) Market Size by Application

10.2.1 Middle East and Africa Flutamide (CAS 13311-84-7) Sales by Application (2017-2028)

10.2.2 Middle East and Africa Flutamide (CAS 13311-84-7) Revenue by Application (2017-2028)

10.3 Middle East and Africa Flutamide (CAS 13311-84-7) Market Size by Country

10.3.1 Middle East and Africa Flutamide (CAS 13311-84-7) Sales by Country (2017-2028)

10.3.2 Middle East and Africa Flutamide (CAS 13311-84-7) Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Forward

11.1.1 Forward Corporation Information

11.1.2 Forward Overview

11.1.3 Forward Flutamide (CAS 13311-84-7) Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Forward Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Forward Recent Developments

11.2 Merck

11.2.1 Merck Corporation Information

11.2.2 Merck Overview

11.2.3 Merck Flutamide (CAS 13311-84-7) Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Merck Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Merck Recent Developments

11.3 Tasly Diyi Pharma

11.3.1 Tasly Diyi Pharma Corporation Information

11.3.2 Tasly Diyi Pharma Overview

11.3.3 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Tasly Diyi Pharma Recent Developments

11.4 Cipla LifeScience

11.4.1 Cipla LifeScience Corporation Information

11.4.2 Cipla LifeScience Overview

11.4.3 Cipla LifeScience Flutamide (CAS 13311-84-7) Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Cipla LifeScience Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Cipla LifeScience Recent Developments

11.5 Actiza Pharma

11.5.1 Actiza Pharma Corporation Information

11.5.2 Actiza Pharma Overview

11.5.3 Actiza Pharma Flutamide (CAS 13311-84-7) Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Actiza Pharma Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Actiza Pharma Recent Developments

11.6 TEVA Pharma

11.6.1 TEVA Pharma Corporation Information

11.6.2 TEVA Pharma Overview

11.6.3 TEVA Pharma Flutamide (CAS 13311-84-7) Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 TEVA Pharma Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 TEVA Pharma Recent Developments

11.7 Florencia Healthcare

11.7.1 Florencia Healthcare Corporation Information

11.7.2 Florencia Healthcare Overview

11.7.3 Florencia Healthcare Flutamide (CAS 13311-84-7) Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Florencia Healthcare Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Florencia Healthcare Recent Developments

11.8 SANDOZ

11.8.1 SANDOZ Corporation Information

11.8.2 SANDOZ Overview

11.8.3 SANDOZ Flutamide (CAS 13311-84-7) Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 SANDOZ Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 SANDOZ Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Flutamide (CAS 13311-84-7) Industry Chain Analysis

12.2 Flutamide (CAS 13311-84-7) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Flutamide (CAS 13311-84-7) Production Mode & Process

12.4 Flutamide (CAS 13311-84-7) Sales and Marketing

12.4.1 Flutamide (CAS 13311-84-7) Sales Channels

12.4.2 Flutamide (CAS 13311-84-7) Distributors

12.5 Flutamide (CAS 13311-84-7) Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Flutamide (CAS 13311-84-7) Industry Trends

13.2 Flutamide (CAS 13311-84-7) Market Drivers

13.3 Flutamide (CAS 13311-84-7) Market Challenges

13.4 Flutamide (CAS 13311-84-7) Market Restraints

14 Key Findings in The Global Flutamide (CAS 13311-84-7) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Flutamide (CAS 13311-84-7) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Flutamide Tablets

Table 3. Major Manufacturers of Flutamide Capsule

Table 4. Major Manufacturers of Others

Table 5. Global Flutamide (CAS 13311-84-7) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Flutamide (CAS 13311-84-7) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Flutamide (CAS 13311-84-7) Sales by Region (2017-2022) & (Kg)

Table 8. Global Flutamide (CAS 13311-84-7) Sales Market Share by Region (2017-2022)

Table 9. Global Flutamide (CAS 13311-84-7) Sales by Region (2023-2028) & (Kg)

Table 10. Global Flutamide (CAS 13311-84-7) Sales Market Share by Region (2023-2028)

Table 11. Global Flutamide (CAS 13311-84-7) Revenue by Region (2017-2022) & (US$ Million)

Table 12. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Region (2017-2022)

Table 13. Global Flutamide (CAS 13311-84-7) Revenue by Region (2023-2028) & (US$ Million)

Table 14. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Region (2023-2028)

Table 15. Global Flutamide (CAS 13311-84-7) Sales by Manufacturers (2017-2022) & (Kg)

Table 16. Global Flutamide (CAS 13311-84-7) Sales Share by Manufacturers (2017-2022)

Table 17. Global Flutamide (CAS 13311-84-7) Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 18. Global Flutamide (CAS 13311-84-7) Revenue Share by Manufacturers (2017-2022)

Table 19. Flutamide (CAS 13311-84-7) Price by Manufacturers (2017-2022) &(USD/Kg)

Table 20. Global Flutamide (CAS 13311-84-7) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 21. Global Flutamide (CAS 13311-84-7) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flutamide (CAS 13311-84-7) as of 2021)

Table 22. Flutamide (CAS 13311-84-7) Manufacturing Base Distribution and Headquarters

Table 23. Manufacturers Flutamide (CAS 13311-84-7) Product Offered

Table 24. Date of Manufacturers Enter into Flutamide (CAS 13311-84-7) Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 27. Global Flutamide (CAS 13311-84-7) Sales by Type (2023-2028) & (Kg)

Table 28. Global Flutamide (CAS 13311-84-7) Sales Share by Type (2017-2022)

Table 29. Global Flutamide (CAS 13311-84-7) Sales Share by Type (2023-2028)

Table 30. Global Flutamide (CAS 13311-84-7) Revenue by Type (2017-2022) & (US$ Million)

Table 31. Global Flutamide (CAS 13311-84-7) Revenue by Type (2023-2028) & (US$ Million)

Table 32. Global Flutamide (CAS 13311-84-7) Revenue Share by Type (2017-2022)

Table 33. Global Flutamide (CAS 13311-84-7) Revenue Share by Type (2023-2028)

Table 34. Flutamide (CAS 13311-84-7) Price by Type (2017-2022) & (USD/Kg)

Table 35. Global Flutamide (CAS 13311-84-7) Price Forecast by Type (2023-2028) & (USD/Kg)

Table 36. Global Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 37. Global Flutamide (CAS 13311-84-7) Sales by Application (2023-2028) & (Kg)

Table 38. Global Flutamide (CAS 13311-84-7) Sales Share by Application (2017-2022)

Table 39. Global Flutamide (CAS 13311-84-7) Sales Share by Application (2023-2028)

Table 40. Global Flutamide (CAS 13311-84-7) Revenue by Application (2017-2022) & (US$ Million)

Table 41. Global Flutamide (CAS 13311-84-7) Revenue by Application (2023-2028) & (US$ Million)

Table 42. Global Flutamide (CAS 13311-84-7) Revenue Share by Application (2017-2022)

Table 43. Global Flutamide (CAS 13311-84-7) Revenue Share by Application (2023-2028)

Table 44. Flutamide (CAS 13311-84-7) Price by Application (2017-2022) & (USD/Kg)

Table 45. Global Flutamide (CAS 13311-84-7) Price Forecast by Application (2023-2028) & (USD/Kg)

Table 46. North America Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 47. North America Flutamide (CAS 13311-84-7) Sales by Type (2023-2028) & (Kg)

Table 48. North America Flutamide (CAS 13311-84-7) Revenue by Type (2017-2022) & (US$ Million)

Table 49. North America Flutamide (CAS 13311-84-7) Revenue by Type (2023-2028) & (US$ Million)

Table 50. North America Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 51. North America Flutamide (CAS 13311-84-7) Sales by Application (2023-2028) & (Kg)

Table 52. North America Flutamide (CAS 13311-84-7) Revenue by Application (2017-2022) & (US$ Million)

Table 53. North America Flutamide (CAS 13311-84-7) Revenue by Application (2023-2028) & (US$ Million)

Table 54. North America Flutamide (CAS 13311-84-7) Sales by Country (2017-2022) & (Kg)

Table 55. North America Flutamide (CAS 13311-84-7) Sales by Country (2023-2028) & (Kg)

Table 56. North America Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022) & (US$ Million)

Table 57. North America Flutamide (CAS 13311-84-7) Revenue by Country (2023-2028) & (US$ Million)

Table 58. Europe Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 59. Europe Flutamide (CAS 13311-84-7) Sales by Type (2023-2028) & (Kg)

Table 60. Europe Flutamide (CAS 13311-84-7) Revenue by Type (2017-2022) & (US$ Million)

Table 61. Europe Flutamide (CAS 13311-84-7) Revenue by Type (2023-2028) & (US$ Million)

Table 62. Europe Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 63. Europe Flutamide (CAS 13311-84-7) Sales by Application (2023-2028) & (Kg)

Table 64. Europe Flutamide (CAS 13311-84-7) Revenue by Application (2017-2022) & (US$ Million)

Table 65. Europe Flutamide (CAS 13311-84-7) Revenue by Application (2023-2028) & (US$ Million)

Table 66. Europe Flutamide (CAS 13311-84-7) Sales by Country (2017-2022) & (Kg)

Table 67. Europe Flutamide (CAS 13311-84-7) Sales by Country (2023-2028) & (Kg)

Table 68. Europe Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022) & (US$ Million)

Table 69. Europe Flutamide (CAS 13311-84-7) Revenue by Country (2023-2028) & (US$ Million)

Table 70. Asia Pacific Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 71. Asia Pacific Flutamide (CAS 13311-84-7) Sales by Type (2023-2028) & (Kg)

Table 72. Asia Pacific Flutamide (CAS 13311-84-7) Revenue by Type (2017-2022) & (US$ Million)

Table 73. Asia Pacific Flutamide (CAS 13311-84-7) Revenue by Type (2023-2028) & (US$ Million)

Table 74. Asia Pacific Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 75. Asia Pacific Flutamide (CAS 13311-84-7) Sales by Application (2023-2028) & (Kg)

Table 76. Asia Pacific Flutamide (CAS 13311-84-7) Revenue by Application (2017-2022) & (US$ Million)

Table 77. Asia Pacific Flutamide (CAS 13311-84-7) Revenue by Application (2023-2028) & (US$ Million)

Table 78. Asia Pacific Flutamide (CAS 13311-84-7) Sales by Region (2017-2022) & (Kg)

Table 79. Asia Pacific Flutamide (CAS 13311-84-7) Sales by Region (2023-2028) & (Kg)

Table 80. Asia Pacific Flutamide (CAS 13311-84-7) Revenue by Region (2017-2022) & (US$ Million)

Table 81. Asia Pacific Flutamide (CAS 13311-84-7) Revenue by Region (2023-2028) & (US$ Million)

Table 82. Latin America Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 83. Latin America Flutamide (CAS 13311-84-7) Sales by Type (2023-2028) & (Kg)

Table 84. Latin America Flutamide (CAS 13311-84-7) Revenue by Type (2017-2022) & (US$ Million)

Table 85. Latin America Flutamide (CAS 13311-84-7) Revenue by Type (2023-2028) & (US$ Million)

Table 86. Latin America Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 87. Latin America Flutamide (CAS 13311-84-7) Sales by Application (2023-2028) & (Kg)

Table 88. Latin America Flutamide (CAS 13311-84-7) Revenue by Application (2017-2022) & (US$ Million)

Table 89. Latin America Flutamide (CAS 13311-84-7) Revenue by Application (2023-2028) & (US$ Million)

Table 90. Latin America Flutamide (CAS 13311-84-7) Sales by Country (2017-2022) & (Kg)

Table 91. Latin America Flutamide (CAS 13311-84-7) Sales by Country (2023-2028) & (Kg)

Table 92. Latin America Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022) & (US$ Million)

Table 93. Latin America Flutamide (CAS 13311-84-7) Revenue by Country (2023-2028) & (US$ Million)

Table 94. Middle East and Africa Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 95. Middle East and Africa Flutamide (CAS 13311-84-7) Sales by Type (2023-2028) & (Kg)

Table 96. Middle East and Africa Flutamide (CAS 13311-84-7) Revenue by Type (2017-2022) & (US$ Million)

Table 97. Middle East and Africa Flutamide (CAS 13311-84-7) Revenue by Type (2023-2028) & (US$ Million)

Table 98. Middle East and Africa Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 99. Middle East and Africa Flutamide (CAS 13311-84-7) Sales by Application (2023-2028) & (Kg)

Table 100. Middle East and Africa Flutamide (CAS 13311-84-7) Revenue by Application (2017-2022) & (US$ Million)

Table 101. Middle East and Africa Flutamide (CAS 13311-84-7) Revenue by Application (2023-2028) & (US$ Million)

Table 102. Middle East and Africa Flutamide (CAS 13311-84-7) Sales by Country (2017-2022) & (Kg)

Table 103. Middle East and Africa Flutamide (CAS 13311-84-7) Sales by Country (2023-2028) & (Kg)

Table 104. Middle East and Africa Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022) & (US$ Million)

Table 105. Middle East and Africa Flutamide (CAS 13311-84-7) Revenue by Country (2023-2028) & (US$ Million)

Table 106. Forward Corporation Information

Table 107. Forward Description and Major Businesses

Table 108. Forward Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 109. Forward Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

Table 110. Forward Recent Developments

Table 111. Merck Corporation Information

Table 112. Merck Description and Major Businesses

Table 113. Merck Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 114. Merck Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Merck Recent Developments

Table 116. Tasly Diyi Pharma Corporation Information

Table 117. Tasly Diyi Pharma Description and Major Businesses

Table 118. Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 119. Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. Tasly Diyi Pharma Recent Developments

Table 121. Cipla LifeScience Corporation Information

Table 122. Cipla LifeScience Description and Major Businesses

Table 123. Cipla LifeScience Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 124. Cipla LifeScience Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. Cipla LifeScience Recent Developments

Table 126. Actiza Pharma Corporation Information

Table 127. Actiza Pharma Description and Major Businesses

Table 128. Actiza Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 129. Actiza Pharma Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. Actiza Pharma Recent Developments

Table 131. TEVA Pharma Corporation Information

Table 132. TEVA Pharma Description and Major Businesses

Table 133. TEVA Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 134. TEVA Pharma Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

Table 135. TEVA Pharma Recent Developments

Table 136. Florencia Healthcare Corporation Information

Table 137. Florencia Healthcare Description and Major Businesses

Table 138. Florencia Healthcare Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 139. Florencia Healthcare Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

Table 140. Florencia Healthcare Recent Developments

Table 141. SANDOZ Corporation Information

Table 142. SANDOZ Description and Major Businesses

Table 143. SANDOZ Flutamide (CAS 13311-84-7) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 144. SANDOZ Flutamide (CAS 13311-84-7) Product Model Numbers, Pictures, Descriptions and Specifications

Table 145. SANDOZ Recent Developments

Table 146. Key Raw Materials Lists

Table 147. Raw Materials Key Suppliers Lists

Table 148. Flutamide (CAS 13311-84-7) Distributors List

Table 149. Flutamide (CAS 13311-84-7) Customers List

Table 150. Flutamide (CAS 13311-84-7) Market Trends

Table 151. Flutamide (CAS 13311-84-7) Market Drivers

Table 152. Flutamide (CAS 13311-84-7) Market Challenges

Table 153. Flutamide (CAS 13311-84-7) Market Restraints

Table 154. Research Programs/Design for This Report

Table 155. Key Data Information from Secondary Sources

Table 156. Key Data Information from Primary Sources

List of Figures

Figure 1. Flutamide (CAS 13311-84-7) Product Picture

Figure 3. Global Flutamide (CAS 13311-84-7) Market Share by Type in 2021 & 2028

Figure 3. Flutamide Tablets Product Picture

Figure 4. Flutamide Capsule Product Picture

Figure 5. Others Product Picture

Figure 6. Global Flutamide (CAS 13311-84-7) Market Share by Application in 2021 & 2028

Figure 7. Hospital Pharmacies

Figure 8. Retail Pharmacies

Figure 9. Online Pharmacies

Figure 10. Flutamide (CAS 13311-84-7) Report Years Considered

Figure 11. Global Flutamide (CAS 13311-84-7) Sales 2017-2028 (Kg)

Figure 12. Global Flutamide (CAS 13311-84-7) Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Flutamide (CAS 13311-84-7) Revenue 2017-2028 (US$ Million)

Figure 14. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 15. Global Flutamide (CAS 13311-84-7) Sales Market Share by Region (2017-2022)

Figure 16. Global Flutamide (CAS 13311-84-7) Sales Market Share by Region (2023-2028)

Figure 17. North America Flutamide (CAS 13311-84-7) Sales YoY (2017-2028) & (Kg)

Figure 18. North America Flutamide (CAS 13311-84-7) Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Europe Flutamide (CAS 13311-84-7) Sales YoY (2017-2028) & (Kg)

Figure 20. Europe Flutamide (CAS 13311-84-7) Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Asia-Pacific Flutamide (CAS 13311-84-7) Sales YoY (2017-2028) & (Kg)

Figure 22. Asia-Pacific Flutamide (CAS 13311-84-7) Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Latin America Flutamide (CAS 13311-84-7) Sales YoY (2017-2028) & (Kg)

Figure 24. Latin America Flutamide (CAS 13311-84-7) Revenue YoY (2017-2028) & (US$ Million)

Figure 25. Middle East & Africa Flutamide (CAS 13311-84-7) Sales YoY (2017-2028) & (Kg)

Figure 26. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue YoY (2017-2028) & (US$ Million)

Figure 27. The Flutamide (CAS 13311-84-7) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 28. The Top 5 and 10 Largest Manufacturers of Flutamide (CAS 13311-84-7) in the World: Market Share by Flutamide (CAS 13311-84-7) Revenue in 2021

Figure 29. Global Flutamide (CAS 13311-84-7) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 30. Global Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2028)

Figure 31. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2028)

Figure 32. Global Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2028)

Figure 33. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2017-2028)

Figure 34. North America Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2028)

Figure 35. North America Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2028)

Figure 36. North America Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2028)

Figure 37. North America Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2017-2028)

Figure 38. North America Flutamide (CAS 13311-84-7) Sales Share by Country (2017-2028)

Figure 39. North America Flutamide (CAS 13311-84-7) Revenue Share by Country (2017-2028)

Figure 40. U.S. Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 41. Canada Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 42. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2028)

Figure 43. Europe Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2028)

Figure 44. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2028)

Figure 45. Europe Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2017-2028)

Figure 46. Europe Flutamide (CAS 13311-84-7) Sales Share by Country (2017-2028)

Figure 47. Europe Flutamide (CAS 13311-84-7) Revenue Share by Country (2017-2028)

Figure 48. Germany Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 49. France Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 50. U.K. Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 51. Italy Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 52. Russia Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 53. Asia Pacific Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2028)

Figure 54. Asia Pacific Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2028)

Figure 55. Asia Pacific Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2028)

Figure 56. Asia Pacific Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2017-2028)

Figure 57. Asia Pacific Flutamide (CAS 13311-84-7) Sales Share by Region (2017-2028)

Figure 58. Asia Pacific Flutamide (CAS 13311-84-7) Revenue Share by Region (2017-2028)

Figure 59. China Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 60. Japan Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 61. South Korea Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 62. India Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 63. Australia Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 64. Taiwan Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 65. Indonesia Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 66. Thailand Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 67. Malaysia Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 68. Philippines Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 69. Latin America Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2028)

Figure 70. Latin America Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2028)

Figure 71. Latin America Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2028)

Figure 72. Latin America Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2017-2028)

Figure 73. Latin America Flutamide (CAS 13311-84-7) Sales Share by Country (2017-2028)

Figure 74. Latin America Flutamide (CAS 13311-84-7) Revenue Share by Country (2017-2028)

Figure 75. Mexico Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 76. Brazil Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 77. Argentina Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 78. Middle East and Africa Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2028)

Figure 80. Middle East and Africa Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Flutamide (CAS 13311-84-7) Sales Share by Country (2017-2028)

Figure 83. Middle East and Africa Flutamide (CAS 13311-84-7) Revenue Share by Country (2017-2028)

Figure 84. Turkey Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 85. Saudi Arabia Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 86. U.A.E Flutamide (CAS 13311-84-7) Revenue (2017-2028) & (US$ Million)

Figure 87. Flutamide (CAS 13311-84-7) Value Chain

Figure 88. Flutamide (CAS 13311-84-7) Production Process

Figure 89. Channels of Distribution

Figure 90. Distributors Profiles

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Flutamide (CAS 13311-84-7) Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-19W7442

Global Flutamide (CAS 13311-84-7) Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions